Kintegral Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Kintegral Advisory's EW Position: Q1 2026 in Review
Kintegral Advisory reduced its Edwards Lifesciences (EW) stake by 4.2% in Q1 2026, selling an estimated $232K and leaving 63,507 shares worth $5.09M. The position accounts for 0.48% of the portfolio, ranked #51.
Kintegral Advisory first reported a position in EW in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.74M in Q2 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Kintegral Advisory held 63,507 shares of Edwards Lifesciences worth $5.09M as of Q1 2026.
- Kintegral Advisory sold 2,816 Edwards Lifesciences shares in Q1 2026, an estimated $232K.
- Edwards Lifesciences made up 0.48% of Kintegral Advisory's portfolio in Q1 2026, its #51 holding.
- Kintegral Advisory first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 30 quarters since.
- Kintegral Advisory's Edwards Lifesciences position peaked at $6.74M in Q2 2024.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Kintegral Advisory's 13F filing for Q1 2026, filed 14 May 2026.